農行(01288.HK)助力「獨角獸」和科創企業發展 貸款及授信餘額逾32億人幣
據《上海證券報》報道,農業銀行(01288.HK)(601288.SH)高度重視「獨角獸」和科創企業金融服務。截至目前,該行已與逾40家「獨角獸」企業以及逾10家科創板上市企業建立合作關係,「獨角獸」客戶貸款餘額14.88億元人民幣(下同),科創企業授信金額17.27億元。
農行公司業務部有關負責人表示,「獨角獸」企業與科創企業代表著內地經濟轉型與產業升級的方向,是商業銀行服務國家戰略、優化信貸結構、提升經營效益的重要抓手。下一步,農行將採取名單制精準服務、支持重點區域、提升專業能力、加強數字化創新、發展資本市場業務等更多前瞻性、針對性的工作措施,推動相關業務加快發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.